[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES550504A0 - Un procedimiento para la preparacion de derivados de podofilotoxina. - Google Patents

Un procedimiento para la preparacion de derivados de podofilotoxina.

Info

Publication number
ES550504A0
ES550504A0 ES550504A ES550504A ES550504A0 ES 550504 A0 ES550504 A0 ES 550504A0 ES 550504 A ES550504 A ES 550504A ES 550504 A ES550504 A ES 550504A ES 550504 A0 ES550504 A0 ES 550504A0
Authority
ES
Spain
Prior art keywords
podofilotoxin
derivatives
procedure
preparation
podofilotoxin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES550504A
Other languages
English (en)
Other versions
ES8701761A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Conpharm AB
Original Assignee
Conpharm AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conpharm AB filed Critical Conpharm AB
Publication of ES8701761A1 publication Critical patent/ES8701761A1/es
Publication of ES550504A0 publication Critical patent/ES550504A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
ES550504A 1984-12-28 1985-12-27 Un procedimiento para la preparacion de derivados de podofilotoxina. Expired ES8701761A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8406660 1984-12-28

Publications (2)

Publication Number Publication Date
ES8701761A1 ES8701761A1 (es) 1986-12-01
ES550504A0 true ES550504A0 (es) 1986-12-01

Family

ID=20358339

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550504A Expired ES8701761A1 (es) 1984-12-28 1985-12-27 Un procedimiento para la preparacion de derivados de podofilotoxina.

Country Status (23)

Country Link
US (1) US4788216A (es)
EP (1) EP0207124B1 (es)
JP (2) JPH0720966B2 (es)
CN (1) CN1006795B (es)
AP (1) AP32A (es)
AT (1) ATE68186T1 (es)
AU (1) AU585936B2 (es)
CA (1) CA1255230A (es)
DE (1) DE3584370D1 (es)
DK (1) DK169506B1 (es)
DZ (1) DZ876A1 (es)
EG (1) EG17788A (es)
ES (1) ES8701761A1 (es)
FI (1) FI89330C (es)
GR (1) GR853145B (es)
HU (1) HU201672B (es)
IL (1) IL77456A (es)
MA (1) MA20602A1 (es)
NO (1) NO863329L (es)
PT (1) PT81760B (es)
TN (1) TNSN86004A1 (es)
WO (1) WO1986004062A1 (es)
ZA (1) ZA859881B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4644072A (en) * 1985-04-12 1987-02-17 Bristol-Myers Company Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
AU632796B2 (en) * 1989-02-23 1993-01-14 University Of North Carolina At Chapel Hill, The Etoposide analogues
SE464167B (sv) 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5338867A (en) * 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
SE9301831D0 (sv) * 1993-05-28 1993-05-28 Analytecon S A Pharmaceutical compositions
GB9422947D0 (en) * 1994-11-14 1995-01-04 Univ Salamanca Immunosuppressive cyclolignan derivatives
US6051721A (en) * 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
FI105152B (fi) 1998-07-17 2000-06-30 Eero Saarela Paikallinen kivunlievitysmenetelmä
US6143304A (en) * 1999-08-17 2000-11-07 The University Of Mississippi Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
SE0102168D0 (sv) 2001-06-19 2001-06-19 Karolinska Innovations Ab New use and new compounds
KR20040030686A (ko) * 2001-06-19 2004-04-09 악셀라르 아베 시클로리그난의 신규의 용도 및 신규의 시클로리그난
SE0203746D0 (sv) * 2002-12-18 2002-12-18 Karolinska Innovations Ab New compounds
KR20110044947A (ko) * 2008-06-23 2011-05-03 악셀라르 아베 과잉활성 면역계 치료를 위한 사이클로리그난의 용도
EP2817007A1 (en) * 2012-02-24 2014-12-31 Nestec S.A. Peltatin for the treatment of chronic inflammatory disorders
WO2015028456A1 (en) * 2013-08-28 2015-03-05 Nestec S.A. PPAR modulators
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA635769A (en) * 1962-01-30 Rutschmann Jurg Amides of podophyllic acid and picropodophyllic acid
SE335139B (es) * 1964-08-12 1971-05-17 Sandoz Ag
US4122092A (en) * 1977-08-25 1978-10-24 University Of Rochester Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
GB8424269D0 (en) * 1984-09-26 1984-10-31 Pharma Medica As Isolation and purification of podophyllotoxin

Also Published As

Publication number Publication date
NO863329D0 (no) 1986-08-19
DK408186D0 (da) 1986-08-27
ES8701761A1 (es) 1986-12-01
EP0207124A1 (en) 1987-01-07
IL77456A0 (en) 1986-08-31
FI863482A (fi) 1986-08-27
JPH0720966B2 (ja) 1995-03-08
PT81760A (en) 1986-01-02
AP8500017A0 (en) 1985-11-01
JPS62501360A (ja) 1987-06-04
CA1255230A (en) 1989-06-06
US4788216A (en) 1988-11-29
JP2572558B2 (ja) 1997-01-16
MA20602A1 (fr) 1986-07-01
IL77456A (en) 1989-07-31
TNSN86004A1 (fr) 1990-01-01
HU201672B (en) 1990-12-28
ZA859881B (en) 1986-09-24
CN85109666A (zh) 1986-10-29
FI863482A0 (fi) 1986-08-27
FI89330B (fi) 1993-06-15
PT81760B (pt) 1987-11-11
DK169506B1 (da) 1994-11-14
ATE68186T1 (de) 1991-10-15
HUT47582A (en) 1989-03-28
AP32A (en) 1988-12-07
AU585936B2 (en) 1989-06-29
DK408186A (da) 1986-08-27
NO863329L (no) 1986-08-19
EG17788A (en) 1990-12-30
FI89330C (fi) 1993-09-27
JPH07173063A (ja) 1995-07-11
EP0207124B1 (en) 1991-10-09
CN1006795B (zh) 1990-02-14
GR853145B (es) 1986-04-29
DZ876A1 (fr) 2004-09-13
WO1986004062A1 (en) 1986-07-17
DE3584370D1 (de) 1991-11-14
AU5300386A (en) 1986-07-29

Similar Documents

Publication Publication Date Title
ES544644A0 (es) Un procedimiento para la preparacion de derivados de carboxamidoadenosina.
ES545464A0 (es) Un procedimiento para la preparacion de tetrahidroftalimidas.
ES540705A0 (es) Un procedimiento para la preparacion de 17b-carbamoil-n-monosustituido -o 17b-acil-4-aza-5-alfa-androstien-3-onas.
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES541200A0 (es) Un procedimiento para la preparacion de un derivado de dibenzoilmetano.
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES546236A0 (es) Un procedimiento para la preparacion de derivados de bencimidasol.
ES548073A0 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES540609A0 (es) Un procedimiento para la preparacion de pirazolo piridinas.
ES540610A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES544521A0 (es) Un procedimiento para la preparacion de triazolobenzodiazefinas.
ES546872A0 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES541781A0 (es) Un procedimiento para la preparacion de nuevos benzotiopenos.
ES550504A0 (es) Un procedimiento para la preparacion de derivados de podofilotoxina.
ES554609A0 (es) Un procedimiento para la preparacion de derivados de oxindol
ES547805A0 (es) Un procedimiento para la preparacion de nuevos derivados de guanina.
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES547205A0 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
ES544221A0 (es) Un procedimiento para la preparacion de derivados de etanolamina.
ES539942A0 (es) Un procedimiento para la preparacion de derivados de hidantoina.
ES545439A0 (es) Un procedimiento para la preparacion de 2-bencil-4-(4-piridil)-tiazoles.
ES542882A0 (es) Un procedimiento para la preparacion de nuevas sulfonilureas.
ES541450A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-heteroazolidindionas.
ES557267A0 (es) Un procedimiento para la preparacion de derivados amidinofenilicos